HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

More in this Section

The €66m Euromillions winning ticket was sold in…

Enda Kenny to turn sod on two Cork projects with potential to transform city centre

Journalists 'cannot work with police protection', says NUJ after gangland threats

Adams isolated in party leaders' debate


You might also like

Today's Stories

VIDEO: Taoiseach and Tánaiste unveil two strategic schemes in Cork

Generations of lovebirds flocked to Hilser's jewellers in Cork

‘Slab’ Murphy sentencing adjourned until polling day

Cork events centre ready to host concerts in two years

Lifestyle

Wine: Beautiful Beaujolais

Inside Vogue magazine's fabulous show-off show in London

Dublin’s Assay Office is worth its weight in gold

Singer-songwriter Aoife O’Donovan comes back to her roots in Cork

More From The Irish Examiner